ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 1, 1999

Primary Completion Date

October 17, 2000

Study Completion Date

September 22, 2008

Conditions
Ovarian Cancer
Interventions
DRUG

ISIS 5132

4mg/kg/day IV for 21 days every 4 weeks.

Trial Locations (66)

10021

Memorial Sloan-Kettering Cancer Center, New York

55805

Duluth Clinic, Duluth

T6G 1Z2

Cross Cancer Institute, Edmonton

T1J 1W5

Lethbridge Cancer Clinic, Lethbridge

V5H 4C2

Burnaby Hospital Regional Cancer Centre, Burnaby

V2A 3G6

Penticton Regional Hospital, Penticton

V3V 1Z2

British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey

V5Z 3J5

Prostate Centre at Vancouver General Hospital, Vancouver

V5Z 4E6

BC Cancer Agency, Vancouver

V6Z 1Y6

St. Paul's Hospital - Vancouver, Vancouver

V8R 1J8

British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria

R3E 0V9

CancerCare Manitoba, Winnipeg

E1C 6ZB

Moncton Hospital, Moncton

E1C 8X3

Doctor Leon Richard Oncology Centre, Moncton

E2L 4L2

Saint John Regional Hospital, Saint John

A1B 3V6

Dr. H. Bliss Murphy Cancer Centre, St. John's

B3H 1V7

Nova Scotia Cancer Centre, Halifax

B3H 2Y9

Queen Elizabeth II Health Science Center, Halifax

L4M 6M2

Royal Victoria Hospital, Barrie, Barrie

L6W 2Z8

Peel Memorial Hospital, Brampton

P3E 5J1

Northeastern Ontario Regional Cancer Centre, Sudbury, Greater Sudbury

L8V 5C2

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton

K7L 5P9

Kingston Regional Cancer Centre, Kingston

N6A 4L6

Cancer Care Ontario-London Regional Cancer Centre, London

L5B 1B8

Trillium Health Centre, Mississauga

L5M 2N1

Credit Valley Hospital, Mississauga

L3Y 2P9

York County Hospital, Newmarket

M2E 1K1

North York General Hospital, Ontario, North York

L1G 2B9

Lakeridge Health Oshawa, Oshawa

K1H 8L6

Ottawa Regional Cancer Center - General Division, Ottawa

K1Y 4K7

Ottawa Regional Cancer Centre - Civic Campus, Ottawa

K9H 7B6

Peterborough Oncology Clinic, Peterborough

P6B 1Y5

Algoma District Medical Group, Sault Ste. Marie

M1P 2V5

Scarborough Hospital - General Site, Scarborough Village

L2R 5K3

Hotel Dieu Hospital - St. Catharines, St. Catharines

P7A 7T1

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay

M4C 3E9

Toronto East General Hospital, Toronto

M4N 3M5

Toronto Sunnybrook Regional Cancer Centre, Toronto

M5B 1W8

St. Michael's Hospital - Toronto, Toronto

M5G 1X5

Mount Sinai Hospital - Toronto, Toronto

M5G 2C4

Toronto General Hospital, Toronto

M5G 2M9

Princess Margaret Hospital, Toronto

M5S 1B6

Women's College Campus, Sunnybrook and Women's College Health Science Center, Toronto

M6R 1B5

Saint Joseph's Health Centre - Toronto, Toronto

M9N 1N8

Humber River Regional Hospital, Weston

N8W 2X3

Cancer Care Ontario - Windsor Regional Cancer Centre, Windsor

C1A 8T5

Queen Elizabeth Hospital, PEI, Charlottetown

J1H 5N4

Centre Universitaire de Sante de l'Estrie, Fleurimont

J6E 6J2

Centre Hospitalier Regional de Lanaudiere, Joliette

H1T 2M4

Maisonneuve-Rosemont Hospital, Montreal

H2W 1S6

McGill University Department of Oncology, Montreal

H2W 1T8

Hotel Dieu de Montreal, Montreal

H2W-W1T8

Centre Hospitalier de l'Universite de Montreal, Montreal

H2X 3J4

Centre Hospitalier de l'Universite' de Montreal - Pavillon Saint-Luc, Montreal, Montreal

H3A 1A1

Royal Victoria Hospital - Montreal, Montreal

H3G 1A4

Montreal General Hospital, Montreal

H3T 1M5

St. Mary's Hospital Center, Montreal

H4A 3L6

Queen Elizabeth Hospital, Montreal, Montreal

H4J 1C5

Hopital Du Sacre-Coeur de Montreal, Montreal

G1R 2J6

Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec, Québec

G1S 4L8

Hopital du Saint-Sacrament, Quebec, Québec

J3A 1B7

Hopital du Haut-Richelieu, Saint-Jean-sur-Richelieu

G1V 4G5

Hopital Laval, Ste-Foy

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

SO14 0YG

Royal South Hants Hospital, Southampton

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK

NCT00003892 - ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer | Biotech Hunter | Biotech Hunter